Phase 2 PTSD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are active duty or retired military service members between 18 and 65 years old
- People who have been diagnosed with PTSD, confirmed through a structured clinical assessment called the Clinician-Administered PTSD Scale
- People who are able to speak and read English, as the study measures have been standardised in English
- People who are registered in the Defense Enrollment Eligibility Reporting System (DEERS) and are eligible to receive care at a military treatment facility where the procedure would be performed (confirm with trial site)
Who may not be able to join:
- People who are currently experiencing serious thoughts of suicide that need immediate attention, as assessed by clinical tools and confirmed by a credentialed provider
- People who are currently experiencing a manic episode or psychotic symptoms that require immediate treatment or hospitalisation
- People who are currently experiencing moderate to severe problems with substance use, including alcohol, that require immediate intervention
- People who have another psychiatric condition that is considered more significant than PTSD, based on a clinician's assessment
- People who are currently pregnant or breastfeeding
- People who are currently taking blood-thinning medications
- People who have a history of a bleeding disorder
- People who have an infection or growth at the site where the injection would be given
- People who have had a heart attack within the 6 months before the procedure
- People who have an abnormally slow heart rate or irregular heart rhythms
- People who have low blood pressure that causes symptoms
- People who have paralysis or impairment of the phrenic or laryngeal nerves (confirm with trial site)
- People who have a history of glaucoma (a condition affecting eye pressure)
- People who have a seizure disorder that is not well controlled
- People who have a known allergy to local anaesthetics (numbing medications)
- People who are currently taking a specific class of heart rhythm medications known as Class III antiarrhythmics (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Alan Peterson, PhD, The University of Texas Health Science Center at San Antonio
Phone: 210-562-6726
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from baseline in Clinician-Administered PTSD Scale-DSM 5 (CAPS-5); Change from baseline in Posttraumatic Stress Disorder Checklist -DSM 5 (PCL-5)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.